Last reviewed · How we verify
Placebo of SPM 962 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of SPM 962 (Placebo of SPM 962) — Otsuka Pharmaceutical Co., Ltd.. Placebos do not have an active pharmacological mechanism; they are used as controls in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of SPM 962 TARGET | Placebo of SPM 962 | Otsuka Pharmaceutical Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of SPM 962 CI watch — RSS
- Placebo of SPM 962 CI watch — Atom
- Placebo of SPM 962 CI watch — JSON
- Placebo of SPM 962 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of SPM 962 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-spm-962. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab